Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions.
Saved in:
| Title: | Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions. |
|---|---|
| Authors: | Pozzar RA; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA. rachel_pozzar@dfci.harvard.edu., Xiong N; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA., Hong F; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA., Filson CP; Emory University, 100 Woodruff Circle, Atlanta, GA, 30322, USA., Chang P; Beth Israel Deaconess Medical Center, 330 Brookline Ave., Boston, MA, 02215, USA., Halpenny B; Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA., Berry DL; University of Washington, 1959 NE Pacific St., Seattle, WA, 98195, USA. |
| Source: | BMC medical informatics and decision making [BMC Med Inform Decis Mak] 2022 Aug 24; Vol. 22 (1), pp. 223. Date of Electronic Publication: 2022 Aug 24. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Randomized Controlled Trial |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101088682 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6947 (Electronic) Linking ISSN: 14726947 NLM ISO Abbreviation: BMC Med Inform Decis Mak Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
